Late toxicity and quality of life from GETUG-AFU 22 study: A randomized phase II trial comparing 6 months of degarelix in combination with radiotherapy to radiotherapy alone for patients with detectable PSA after radical prostatectomy

Autor: P. Sargos, S. Guerif, J. Fraisse, E. Meyer, S. Supiot, E. Lagneau, E. Deniaud-Alexandre, P. Rochin, A. Benyoucef, L. Cartier, H. Hamidou, A. Hasbini, G. Crehange, P. Pommier, G. De Laroche, S. Pelissier, E. Gross, P. Fourneret, L. Salomon, I. Latorzeff
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: European Urology Open Science, Vol 19, Iss , Pp e1398-e1399 (2020)
Druh dokumentu: article
ISSN: 2666-1683
DOI: 10.1016/S2666-1683(20)33522-9
Databáze: Directory of Open Access Journals